These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 11356715)

  • 1. Systemic administration of insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) increases bone formation parameters in mice by increasing IGF bioavailability via an IGFBP-4 protease-dependent mechanism.
    Miyakoshi N; Qin X; Kasukawa Y; Richman C; Srivastava AK; Baylink DJ; Mohan S
    Endocrinology; 2001 Jun; 142(6):2641-8. PubMed ID: 11356715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of recombinant insulin-like growth factor-binding protein-4 on bone formation parameters in mice.
    Miyakoshi N; Richman C; Qin X; Baylink DJ; Mohan S
    Endocrinology; 1999 Dec; 140(12):5719-28. PubMed ID: 10579337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that IGF-binding protein-5 functions as a growth factor.
    Miyakoshi N; Richman C; Kasukawa Y; Linkhart TA; Baylink DJ; Mohan S
    J Clin Invest; 2001 Jan; 107(1):73-81. PubMed ID: 11134182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the role of human insulin-like growth factor-II (IGF-II)-dependent IGF binding protein (hIGFBP)-4 protease in human osteoblasts using protease-resistant IGFBP-4 analogs.
    Qin X; Byun D; Strong DD; Baylink DJ; Mohan S
    J Bone Miner Res; 1999 Dec; 14(12):2079-88. PubMed ID: 10620067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo.
    Richman C; Baylink DJ; Lang K; Dony C; Mohan S
    Endocrinology; 1999 Oct; 140(10):4699-705. PubMed ID: 10499528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta regulation of the insulin-like growth factor binding protein-4 protease system in cultured human osteoblasts.
    Ortiz CO; Chen BK; Bale LK; Overgaard MT; Oxvig C; Conover CA
    J Bone Miner Res; 2003 Jun; 18(6):1066-72. PubMed ID: 12817760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The insulin-like growth factor-binding protein-4 (IGFBP-4)-IGFBP-4 protease system in normal human osteoblast-like cells: regulation by transforming growth factor-beta.
    Durham SK; Riggs BL; Conover CA
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1752-8. PubMed ID: 7527411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy-associated plasma protein-A accounts for the insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) proteolytic activity in human pregnancy serum and enhances the mitogenic activity of IGF by degrading IGFBP-4 in vitro.
    Byun D; Mohan S; Yoo M; Sexton C; Baylink DJ; Qin X
    J Clin Endocrinol Metab; 2001 Feb; 86(2):847-54. PubMed ID: 11158056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A protease-resistant form of insulin-like growth factor (IGF) binding protein 4 inhibits IGF-1 actions.
    Rees C; Clemmons DR; Horvitz GD; Clarke JB; Busby WH
    Endocrinology; 1998 Oct; 139(10):4182-8. PubMed ID: 9751498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture.
    Imai Y; Busby WH; Smith CE; Clarke JB; Garmong AJ; Horwitz GD; Rees C; Clemmons DR
    J Clin Invest; 1997 Nov; 100(10):2596-605. PubMed ID: 9366575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that the interaction between insulin-like growth factor (IGF)-II and IGF binding protein (IGFBP)-4 is essential for the action of the IGF-II-dependent IGFBP-4 protease.
    Qin X; Byun D; Lau KH; Baylink DJ; Mohan S
    Arch Biochem Biophys; 2000 Jul; 379(2):209-16. PubMed ID: 10898936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation.
    Yeh LC; Adamo ML; Olson MS; Lee JC
    Endocrinology; 1997 Oct; 138(10):4181-90. PubMed ID: 9322928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of insulin-like growth factor binding protein 4 by a specific insulin-like growth factor binding protein 4 proteinase in normal human osteoblast-like cells: implications in bone cell physiology.
    Durham SK; Kiefer MC; Riggs BL; Conover CA
    J Bone Miner Res; 1994 Jan; 9(1):111-7. PubMed ID: 7512304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on human pregnancy-induced insulin-like growth factor (IGF)-binding protein-4 proteases in serum: determination of IGF-II dependency and localization of cleavage site.
    Byun D; Mohan S; Kim C; Suh K; Yoo M; Lee H; Baylink DJ; Qin X
    J Clin Endocrinol Metab; 2000 Jan; 85(1):373-81. PubMed ID: 10634413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted disruption of the pregnancy-associated plasma protein-A gene is associated with diminished smooth muscle cell response to insulin-like growth factor-I and resistance to neointimal hyperplasia after vascular injury.
    Resch ZT; Simari RD; Conover CA
    Endocrinology; 2006 Dec; 147(12):5634-40. PubMed ID: 16959843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of an insulin-like growth factor-binding protein-4 protease that is secreted by smooth muscle cells.
    Parker A; Gockerman A; Busby WH; Clemmons DR
    Endocrinology; 1995 Jun; 136(6):2470-6. PubMed ID: 7538463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor (IGF)-I, -II, IGF binding proteins (IGFBP)-3, -4, and -5 levels in the conditioned media of normal human bone cells are skeletal site-dependent.
    Malpe R; Baylink DJ; Linkhart TA; Wergedal JE; Mohan S
    J Bone Miner Res; 1997 Mar; 12(3):423-30. PubMed ID: 9076585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy-associated plasma protein A proteolytic activity is associated with the human placental trophoblast cell membrane.
    Sun IY; Overgaard MT; Oxvig C; Giudice LC
    J Clin Endocrinol Metab; 2002 Nov; 87(11):5235-40. PubMed ID: 12414897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of therapy with recombinant human growth hormone on insulin-like growth factor system components and serum levels of biochemical markers of bone formation in children after severe burn injury.
    Klein GL; Wolf SE; Langman CB; Rosen CJ; Mohan S; Keenan BS; Matin S; Steffen C; Nicolai M; Sailer DE; Herndon DN
    J Clin Endocrinol Metab; 1998 Jan; 83(1):21-4. PubMed ID: 9435411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.